K Pharma,Inc. (4896) Stock Statistics & Valuation Metrics

K Pharma,Inc. has a market cap or net worth of ¥8.46B. The enterprise value is ¥6.37B.

K Pharma,Inc. has 11,622,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

K Pharma,Inc.’s return on equity (ROE) is -0.78 and return on invested capital (ROIC) is -32.28%.

The current PE Ratio of K Pharma,Inc. is ―. K Pharma,Inc.’s PEG ratio is -0.44.

In the last 12 months, K Pharma,Inc. had revenue of 0.00 and earned -993.23M in profits. Earnings per share was -85.59.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

K Pharma,Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

K Pharma,Inc. upcoming earnings date is Aug 13, 2026, TBA (Confirmed).

K Pharma,Inc. as a current ratio of 28.41, with Debt / Equity ratio of ―

In the past 12 months, K Pharma,Inc. has paid 2.73M in taxes.

K Pharma,Inc. EV to EBITDA ratio is -6.48, with an EV/FCF ratio of -6.85.

K Pharma,Inc. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for K Pharma,Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―